Position in JNJ
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$46,803,369
+$27,863,669 QoQ
Shares Held
184,287
+137.8% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
1.31%
of 13F equity value
Holder Rank
#461
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Brookstone Capital Management holds $235,547,820 across 12 Drug Manufacturers - General names. JNJ ranks #2 (19.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
65,395 | $78,436,731 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
184,287 | $46,803,369 | |
| 3 | AMGN |
Amgen Inc
|
97,295 | $35,232,465 | |
| 4 | ABBV |
AbbVie Inc.
|
91,033 | $22,907,544 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
144,784 | $18,292,010 | |
| 6 | MRK |
Merck & Co., Inc.
|
130,290 | $16,742,265 | |
| 7 | PFE |
Pfizer Inc
|
272,912 | $6,571,720 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
94,227 | $5,429,359 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $46,803,369 | 184,287 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $18,939,700 | 77,482 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $14,907,850 | 72,036 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $13,206,539 | 71,225 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $11,521,627 | 75,428 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $12,196,536 | 73,544 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $10,462,533 | 72,345 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $11,961,810 | 73,811 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $10,226,669 | 69,969 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $13,685,966 | 86,516 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $10,858,790 | 69,279 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $10,683,827 | 68,596 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $9,426,860 | 56,953 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $9,055,410 | 58,422 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $10,126,461 | 57,325 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $9,284,402 | 56,834 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $10,635,156 | 59,913 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $10,102,287 | 57,001 | Shares | Sole | 2022-04-12 | |
| 2021-12-31 | $9,676,403 | 56,564 | Shares | Sole | 2022-01-11 | |
| 2021-09-30 | $9,140,415 | 56,597 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $8,520,682 | 51,722 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $4,973,559 | 30,262 | Shares | Sole | 2021-04-16 | |
| 2020-12-31 | $4,408,056 | 28,009 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $4,526,994 | 30,407 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $3,575,658 | 25,426 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $3,443,473 | 26,260 | Shares | Sole | 2020-04-14 | |
| No filing history on record for this holder in this stock. | ||||||